|
2025
|
Invention
|
Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 a... |
|
|
Invention
|
Chromatography column qualification in manufacturing methods for producing anti-il12/23 antibody ... |
|
|
Invention
|
Radiolabeling of polypeptides.
Improved methods of radiolabeling antibodies using click chemistr... |
|
|
Invention
|
Il-23 specific antibodies for the treatment of systemic sclerosis.
A method of treating systemic... |
|
2024
|
Invention
|
Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase.
Engineere... |
|
|
Invention
|
Gprc5d antibodies with enhanced effector function and uses thereof.
Herein are antibodies or ant... |
|
|
Invention
|
Gprc5d antibodies with enhanced effector function and uses thereof. Herein are antibodies or anti... |
|
|
Invention
|
Cd33 antibodies, cd33/vδ2 multispecific antibodies and uses thereof. CD33 antibodies, and antigen... |
|
|
Invention
|
Compositions and methods to discover targeted oligonucleotide conjugates. A method of selecting a... |
|
|
Invention
|
Ai models, systems, and methods for predicting remanufacturing failures in car t drug products. S... |
|
|
Invention
|
Ai models, systems, and methods for manufacturing car t drug products with improved dose. Systems... |
|
|
Invention
|
Ai models, systems, and methods for manufacturing car t drug products with improved viability. Sy... |
|
|
Invention
|
Manufacturing systems, methods, and ai models for car t drug products with improved safety. Syste... |
|
|
Invention
|
Manufacturing systems, methods, and ai models for reducing out of specification (oos) car t drug ... |
|
|
Invention
|
Ai models, systems, and methods for reducing manufacturing failures in car t drug products. Syste... |
|
|
Invention
|
Ai models, systems, and methods for reducing growth terminations in car t cells. Systems and meth... |
|
|
Invention
|
Manufacturing systems, methods, and ai models for optimizing car t drug products. Embodiments her... |
|
|
Invention
|
Improved manufacturing of car t drug products based on car. Systems and methods are disclosed for... |
|
|
Invention
|
Methods for treatment of myeloproliferative neoplasms. Methods of inhibiting the growth or prolif... |
|
|
Invention
|
Method of treating psoriasis with anti-il23 specific antibody.
A method of treating psoriasis in... |
|
|
Invention
|
Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or pharm... |
|
|
Invention
|
Methods for treating high-risk smoldering multiple myeloma. Embodiments relate to methods of trea... |
|
|
Invention
|
Methods for treating multiple myeloma. Embodiments of the present invention relate to methods of ... |
|
|
Invention
|
Combination regimens for treating multiple myeloma. Embodiments of the present invention relate t... |
|
|
Invention
|
Compositions comprising enhanced multispecific binding agents for an immune response. Disclosed h... |
|
|
Invention
|
Combination treatment of prostate cancers with two bispecific antibodies. The application describ... |
|
|
Invention
|
First line treatment in egfr exon 20 insertion-mutated advanced non-small cell lung cancer. The p... |
|
|
Invention
|
Methods for treating multiple myeloma comprising an anti-cd38 antibody combined with bortezomib, ... |
|
|
Invention
|
Methods of treating crohn's disease with anti-il23 specific antibody.
A method of treating Crohn... |
|
|
Invention
|
Improved methods in lentiviral manufacturing for production of car-t cell drug products. The pres... |
|
|
Invention
|
Methods for treating macular degeneration. Disclosed herein are methods of treating geographic at... |
|
|
Invention
|
Compositions and methods for the generation of engineered, and or engineerable, cells. The presen... |
|
|
Invention
|
Accessories for drug injection devices. Provided herein are accessories for drug injection device... |
|
|
Invention
|
Methods and materials for scalable 3d cellular redifferentiation. Methods and materials for the c... |
|
|
Invention
|
Proteins comprising cd3 antigen binding domains and uses thereof.
The disclosure provides antige... |
|
|
Invention
|
Method and apparatus for facilitating access to an eye. An ocular access instrument (20) includes... |
|
|
Invention
|
Anti-cd20 x anti-cd28 combination therapies.
Provided herein are novel anti-CD20 x anti-CD28 ant... |
|
|
Invention
|
Approved products for the treatment of relapsed or refractory multiple myeloma.
Described herein... |
|
|
Invention
|
Methods of treating cancers and enhancing efficacy of bcmaxcd3 bispecific antibodies.
Disclosed ... |
|
|
Invention
|
Enpp3 and cd3 binding agents and methods of use thereof.
The present disclosure provides ENPP3 b... |
|
|
Invention
|
Stabilized cd3 antigen binding agents and methods of use thereof.
Stabilized CD3 antigen binding... |
|
2023
|
Invention
|
Enhanced transfer of genetic instructions to effector immune cells.
A method for preparing an im... |
|
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma. Provided herein are methods of treating a ... |
|
|
Invention
|
Materials and methods for enhanced bioproduction processes.
Provided herein is a method for redu... |
|
|
Invention
|
Iimmunoconjugates comprising kallikrein related peptidase 2 antigen binding domains and their use... |
|
2022
|
Invention
|
Microfluidic co-encapsulation device and system and methods for identifying t-cell receptor ligan... |
|
|
Invention
|
Macrocyclic compounds and diagnostic uses thereof.
The present invention is directed to compound... |
|
|
Invention
|
Compositions and methods for the modulation of beta chain-mediated immunity.
Anti-Vβ17 antibodie... |
|
|
Invention
|
Methods for enhanced bcma immunohistochemistry detection in human and monkey tissue.
Provided he... |
|
|
Invention
|
Materials and methods of making or using il-23r binding proteins.
The present invention relates ... |
|
2019
|
P/S
|
Operating an online-marketplace featuring cell and gene therapy treatments and services; business... |
|
2016
|
P/S
|
Software as a service (SAAS) services, namely, hosting software for use by others for ordering, t... |
|
2008
|
P/S
|
Pharmaceutical and veterinary preparations, pharmaceutical preparations for the prevention and tr... |
|
2007
|
P/S
|
patient assistance program, namely, financial assistance for patients receiving pharmaceutical pr... |
|
2003
|
P/S
|
Pharmaceutical for the treatment of autoimmune diseases and autoimmune disorders. |
|
2002
|
P/S
|
pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
2001
|
P/S
|
Medical device used to infuse pharmaceuticals. |
|
|
P/S
|
Pharmaceutical for treatment of autoimmune diseases and disorders. |
|
1998
|
P/S
|
Pharmaceutical and medical preparations and substances; pharmaceutical compositions for the treat... |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders. |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders |
|
1996
|
P/S
|
Pharmaceutical preparations and products. |
|
1994
|
P/S
|
Pharmaceutical preparations for prevention and treatment of disease of the circulatory system. |
|
|
P/S
|
pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system |
